GALMED PHARMACEUTICALS LTD's ticker is GLMD and the CUSIP is M47238106. A total of 26 filers reported holding GALMED PHARMACEUTICALS LTD in Q3 2021. The put-call ratio across all filers is 6.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $11,899 | -14.7% | 27,900 | 0.0% | 0.00% | – |
| Q4 2022 | $13,950 | -22.5% | 27,900 | -52.2% | 0.00% | – |
| Q3 2022 | $18,000 | -57.1% | 58,310 | -9.3% | 0.00% | – |
| Q2 2022 | $42,000 | -58.4% | 64,310 | +1.6% | 0.00% | – |
| Q1 2022 | $101,000 | +124.4% | 63,310 | +158.9% | 0.00% | – |
| Q4 2021 | $45,000 | -23.7% | 24,454 | +14.8% | 0.00% | – |
| Q3 2021 | $59,000 | +15.7% | 21,304 | +27.2% | 0.00% | – |
| Q2 2021 | $51,000 | -13.6% | 16,749 | -2.0% | 0.00% | – |
| Q1 2021 | $59,000 | – | 17,087 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|